Detalhe da pesquisa
1.
SARS-CoV-2 Omicron boosting induces de novo B cell response in humans.
Nature
; 617(7961): 592-598, 2023 May.
Artigo
Inglês
| MEDLINE | ID: mdl-37011668
2.
A Bivalent Omicron-Containing Booster Vaccine against Covid-19.
N Engl J Med
; 387(14): 1279-1291, 2022 10 06.
Artigo
Inglês
| MEDLINE | ID: mdl-36112399
3.
Interim report of the reactogenicity and immunogenicity of SARS-CoV-2 XBB-containing vaccines.
J Infect Dis
; 2024 Feb 13.
Artigo
Inglês
| MEDLINE | ID: mdl-38349280
4.
Neutralization of SARS-CoV-2 Omicron BA.2.75 after mRNA-1273 Vaccination.
N Engl J Med
; 387(13): 1234-1236, 2022 09 29.
Artigo
Inglês
| MEDLINE | ID: mdl-36083119
5.
Neutralization of Omicron Subvariant BA.2.75 after Bivalent Vaccination.
N Engl J Med
; 387(23): 2194-2196, 2022 12 08.
Artigo
Inglês
| MEDLINE | ID: mdl-36416761
6.
SARS-CoV-2 Omicron Variant Neutralization after mRNA-1273 Booster Vaccination.
N Engl J Med
; 386(11): 1088-1091, 2022 03 17.
Artigo
Inglês
| MEDLINE | ID: mdl-35081298
7.
Profiling antibody epitopes induced by mRNA-1273 vaccination and boosters.
Front Immunol
; 15: 1285278, 2024.
Artigo
Inglês
| MEDLINE | ID: mdl-38562934
8.
Three-month antibody persistence of a bivalent Omicron-containing booster vaccine against COVID-19.
Nat Commun
; 14(1): 5125, 2023 08 23.
Artigo
Inglês
| MEDLINE | ID: mdl-37612300
9.
Original SARS-CoV-2 monovalent and Omicron BA.4/BA.5 bivalent COVID-19 mRNA vaccines: phase 2/3 trial interim results.
Nat Med
; 29(9): 2325-2333, 2023 09.
Artigo
Inglês
| MEDLINE | ID: mdl-37653342
10.
Omicron BA.1-containing mRNA-1273 boosters compared with the original COVID-19 vaccine in the UK: a randomised, observer-blind, active-controlled trial.
Lancet Infect Dis
; 23(9): 1007-1019, 2023 09.
Artigo
Inglês
| MEDLINE | ID: mdl-37348519
11.
Amyloid-Related Imaging Abnormalities in 2 Phase 3 Studies Evaluating Aducanumab in Patients With Early Alzheimer Disease.
JAMA Neurol
; 79(1): 13-21, 2022 01 01.
Artigo
Inglês
| MEDLINE | ID: mdl-34807243
12.
Safety and Immunogenicity of a 100 µg mRNA-1273 Vaccine Booster for Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2).
medRxiv
; 2022 Mar 07.
Artigo
Inglês
| MEDLINE | ID: mdl-35291289
13.
Safety, immunogenicity and antibody persistence of a bivalent Beta-containing booster vaccine against COVID-19: a phase 2/3 trial.
Nat Med
; 28(11): 2388-2397, 2022 11.
Artigo
Inglês
| MEDLINE | ID: mdl-36202997
14.
SARS-CoV-2 Omicron boosting induces de novo B cell response in humans.
bioRxiv
; 2022 Sep 22.
Artigo
Inglês
| MEDLINE | ID: mdl-36172127
15.
A case of bovine valve endocarditis caused by Engyodontium album.
Med Mycol
; 49(4): 430-4, 2011 May.
Artigo
Inglês
| MEDLINE | ID: mdl-21108570
16.
Long-term safety and efficacy of daclizumab beta in relapsing-remitting multiple sclerosis: 6-year results from the SELECTED open-label extension study.
J Neurol
; 267(10): 2851-2864, 2020 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-32451615
17.
The development of sarcoidosis in patients receiving daclizumab: A case series from multiple clinical trials.
Respir Med
; 149: 23-27, 2019 03.
Artigo
Inglês
| MEDLINE | ID: mdl-30885425
18.
Effect of Bismuth Subsalicylate on Gastrointestinal Tolerability in Healthy Volunteers Receiving Oral Delayed-release Dimethyl Fumarate: PREVENT, a Randomized, Multicenter, Double-blind, Placebo-controlled Study.
Clin Ther
; 40(12): 2021-2030.e1, 2018 12.
Artigo
Inglês
| MEDLINE | ID: mdl-30447891
19.
ViroFind: A novel target-enrichment deep-sequencing platform reveals a complex JC virus population in the brain of PML patients.
PLoS One
; 13(1): e0186945, 2018.
Artigo
Inglês
| MEDLINE | ID: mdl-29360822